Drugs with Dosage: INJECTABLE;IV (INFUSION), SUBCUTANEOUS
✉ Email this page to a colleague
Drugs with Dosage: INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | Dosage |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic Global | TREPROSTINIL | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 211574-001 | Feb 11, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | |||
Alembic Global | TREPROSTINIL | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 211574-002 | Feb 11, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | |||
Alembic Global | TREPROSTINIL | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 211574-003 | Feb 11, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | |||
Alembic Global | TREPROSTINIL | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 211574-004 | Feb 11, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration | >Dosage |